Published in Environ Health Perspect on July 01, 1999
Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk? Environ Health Perspect (2000) 5.72
Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect (2004) 4.16
Associations between air pollution and mortality in Phoenix, 1995-1997. Environ Health Perspect (2000) 3.77
Airborne particles are a risk factor for hospital admissions for heart and lung disease. Environ Health Perspect (2000) 3.74
Short-term effects of particulate air pollution on cardiovascular diseases in eight European cities. J Epidemiol Community Health (2002) 3.29
Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax (2005) 3.12
Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med (2008) 3.00
Effects of air pollution on heart rate variability: the VA normative aging study. Environ Health Perspect (2005) 2.80
Air pollution and blood markers of cardiovascular risk. Environ Health Perspect (2001) 2.79
Nanoparticles - known and unknown health risks. J Nanobiotechnology (2004) 2.73
Effects of air pollution on blood pressure: a population-based approach. Am J Public Health (2001) 2.64
Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect (2001) 2.64
Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect (2005) 2.57
Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect (2001) 2.38
Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect (2005) 2.36
Traffic-related air pollution and acute changes in heart rate variability and respiratory function in urban cyclists. Environ Health Perspect (2011) 2.12
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect (2004) 1.70
Toxicologic and epidemiologic clues from the characterization of the 1952 London smog fine particulate matter in archival autopsy lung tissues. Environ Health Perspect (2003) 1.66
Air pollution and ST-segment depression in elderly subjects. Environ Health Perspect (2005) 1.56
Particulate air pollution, progression, and survival after myocardial infarction. Environ Health Perspect (2007) 1.52
Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia. Environ Health Perspect (2002) 1.52
Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Perspect (2005) 1.46
Measurement of offline exhaled nitric oxide in a study of community exposure to air pollution. Environ Health Perspect (2003) 1.46
Association of heart rate variability in taxi drivers with marked changes in particulate air pollution in Beijing in 2008. Environ Health Perspect (2010) 1.45
Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol (2009) 1.45
Association between short term exposure to fine particulate matter and heart rate variability in older subjects with and without heart disease. Thorax (2005) 1.42
Coarse particles and heart rate variability among older adults with coronary artery disease in the Coachella Valley, California. Environ Health Perspect (2006) 1.36
An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis. Heart (2012) 1.35
Personal exposure to submicrometer particles and heart rate variability in human subjects. Environ Health Perspect (2004) 1.35
Airway reflexes, autonomic function, and cardiovascular responses. Environ Health Perspect (2001) 1.34
Heart rate variability, ambient particulate matter air pollution, and glucose homeostasis: the environmental epidemiology of arrhythmogenesis in the women's health initiative. Am J Epidemiol (2009) 1.34
Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area. Occup Environ Med (2006) 1.33
Environmental inequality and circulatory disease mortality gradients. J Epidemiol Community Health (2005) 1.28
Effects of diesel exhaust inhalation on heart rate variability in human volunteers. Environ Res (2008) 1.27
Temperature modifies the health effects of particulate matter in Brisbane, Australia. Int J Biometeorol (2006) 1.26
Criteria air pollutants and toxic air pollutants. Environ Health Perspect (2000) 1.25
The relationship between ambient air pollution and heart rate variability differs for individuals with heart and pulmonary disease. Environ Health Perspect (2006) 1.25
Particulate matter, sulfur dioxide, and daily mortality in Chongqing, China. Environ Health Perspect (2003) 1.24
Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma. Environ Health Perspect (2007) 1.22
Exposure to concentrated coarse air pollution particles causes mild cardiopulmonary effects in healthy young adults. Environ Health Perspect (2009) 1.21
Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol (2010) 1.16
Is the association of airborne particles with daily deaths confounded by gaseous air pollutants? An approach to control by matching. Environ Health Perspect (2004) 1.14
Individual-level PM₂.₅ exposure and the time course of impaired heart rate variability: the APACR Study. J Expo Sci Environ Epidemiol (2010) 1.14
Autonomic effects of controlled fine particulate exposure in young healthy adults: effect modification by ozone. Environ Health Perspect (2009) 1.11
Ambient particulate air pollution and ectopy--the environmental epidemiology of arrhythmogenesis in Women's Health Initiative Study, 1999-2004. J Toxicol Environ Health A (2009) 1.10
Vascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among welders. Am J Epidemiol (2009) 1.08
Air pollution and cardiovascular admissions association in Spain: results within the EMECAS project. J Epidemiol Community Health (2006) 1.08
Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals. Part Fibre Toxicol (2010) 1.07
Effects of particle size fractions on reducing heart rate variability in cardiac and hypertensive patients. Environ Health Perspect (2005) 1.06
Occupational exposure to particulate air pollution and mortality due to ischaemic heart disease and cerebrovascular disease. Occup Environ Med (2007) 1.05
Ozone and limonene in indoor air: a source of submicron particle exposure. Environ Health Perspect (2000) 1.04
Acute adverse effects of fine particulate air pollution on ventricular repolarization. Environ Health Perspect (2010) 1.02
Obesity is associated with impaired cardiac autonomic modulation in children. Int J Pediatr Obes (2010) 1.02
Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume. Int Arch Occup Environ Health (2006) 1.00
Ambient Coarse Particulate Matter and Human Health: A Systematic Review and Meta-Analysis. Curr Environ Health Rep (2014) 1.00
Out-of-hospital cardiac arrest and airborne fine particulate matter: a case-crossover analysis of emergency medical services data in Indianapolis, Indiana. Environ Health Perspect (2008) 0.99
Acute effects of fine particulate air pollution on cardiac arrhythmia: the APACR study. Environ Health Perspect (2011) 0.98
Short-term changes in ambient particulate matter and risk of stroke: a systematic review and meta-analysis. J Am Heart Assoc (2014) 0.97
Right heart pressure increases after acute increases in ambient particulate concentration. Environ Health Perspect (2008) 0.96
Exposure to traffic pollution, acute inflammation and autonomic response in a panel of car commuters. Environ Res (2014) 0.96
Exposure to inhaled particulate matter impairs cardiac function in senescent mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.95
Air pollution and health: emerging information on susceptible populations. Air Qual Atmos Health (2012) 0.91
Mortality and air pollution: associations persist with continued advances in research methodology. Environ Health Perspect (1999) 0.90
Is the tobacco control movement misrepresenting the acute cardiovascular health effects of secondhand smoke exposure? An analysis of the scientific evidence and commentary on the implications for tobacco control and public health practice. Epidemiol Perspect Innov (2007) 0.90
Identifying and managing adverse environmental health effects: 2. Outdoor air pollution. CMAJ (2002) 0.89
Associations of short-term particle and noise exposures with markers of cardiovascular and respiratory health among highway maintenance workers. Environ Health Perspect (2014) 0.89
Cardiac oxidative stress and dysfunction by fine concentrated ambient particles (CAPs) are mediated by angiotensin-II. Inhal Toxicol (2010) 0.89
A national case-crossover analysis of the short-term effect of PM2.5 on hospitalizations and mortality in subjects with diabetes and neurological disorders. Environ Health (2014) 0.87
Acute exposure to elevated PM2.5 generated by traffic and cardiopulmonary health effects in healthy older adults. J Expo Sci Environ Epidemiol (2008) 0.87
Metal particulate matter components affect gene expression and beat frequency of neonatal rat ventricular myocytes. Environ Health Perspect (2004) 0.87
Nanotoxicity overview: nano-threat to susceptible populations. Int J Mol Sci (2014) 0.86
A novel methodology to evaluate health impacts caused by VOC exposures using real-time VOC and Holter monitors. Int J Environ Res Public Health (2010) 0.86
Association between fine particulate matter and oxidative DNA damage may be modified in individuals with hypertension. J Occup Environ Med (2009) 0.85
Short-term effects of particulate matter on stroke attack: meta-regression and meta-analyses. PLoS One (2014) 0.85
Survival analysis of long-term exposure to different sizes of airborne particulate matter and risk of infant mortality using a birth cohort in Seoul, Korea. Environ Health Perspect (2010) 0.85
Effects of concentrated ambient particles on heart rate and blood pressure in pulmonary hypertensive rats. Environ Health Perspect (2003) 0.85
Why cardiologists should be interested in air pollution. Heart (2003) 0.84
Acute effects of fine particulate air pollution on ST segment height: a longitudinal study. Environ Health (2010) 0.83
Ischemic heart disease and ambient air pollution of particulate matter 2.5 in 51 counties in the U.S. Public Health Rep (2007) 0.81
Differential effects of inhalation exposure to PM2.5 on hypothalamic monoamines and corticotrophin releasing hormone in lean and obese rats. Neurotoxicology (2012) 0.81
The emerging role of outdoor and indoor air pollution in cardiovascular disease. N Am J Med Sci (2013) 0.81
Structural equation modeling of parasympathetic and sympathetic response to traffic air pollution in a repeated measures study. Environ Health (2013) 0.80
Association of air pollution and use of glyceryl trinitrate against angina pectoris: a population-based case-crossover study. Environ Health (2013) 0.80
The effects of fine particulate air pollution on daily mortality: a case-crossover study in a subtropical city, Taipei, Taiwan. Int J Environ Res Public Health (2014) 0.80
Household concentrations and personal exposure of PM2.5 among urban residents using different cooking fuels. Sci Total Environ (2016) 0.78
Comparison of heart rate variability and cardiac arrhythmias in polluted and clean air episodes in healthy individuals. Environ Health Prev Med (2010) 0.77
Is volcanic air pollution associated with decreased heart-rate variability? Heart Asia (2010) 0.77
Study of personal-indoor-ambient fine particulate matters among school communities in mixed urban-industrial environment in India. Environ Monit Assess (2009) 0.77
In-situ Real-Time Monitoring of Volatile Organic Compound Exposure and Heart Rate Variability for Patients with Multiple Chemical Sensitivity. Int J Environ Res Public Health (2015) 0.76
Endothelial damage due to air pollution. Heart Int (2006) 0.76
The search for non-linear exposure-response relationships at ambient levels in environmental epidemiology. Nonlinearity Biol Toxicol Med (2005) 0.76
Association of air pollution sources and aldehydes with biomarkers of blood coagulation, pulmonary inflammation, and systemic oxidative stress. J Expo Sci Environ Epidemiol (2016) 0.75
Biomarkers of Human Cardiopulmonary Response After Short-Term Exposures to Medical Laser-Generated Particulate Matter From Simulated Procedures: A Pilot Study. J Occup Environ Med (2016) 0.75
Associations of particulate matter and its components with emergency room visits for cardiovascular and respiratory diseases. PLoS One (2017) 0.75
Air quality effects of traffic in a canyon-like street (Falmouth, U.K.). Environ Monit Assess (2003) 0.75
An Ensemble Spatiotemporal Model for Predicting PM2.5 Concentrations. Int J Environ Res Public Health (2017) 0.75
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (1981) 10.62
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10
Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res (1986) 8.69
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol (1985) 5.67
Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol (1995) 4.24
Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology (1997) 3.50
Personal sampling of particles in adults: relation among personal, indoor, and outdoor air concentrations. Am J Epidemiol (1998) 3.44
Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.98
Air pollution and hospital admissions for the elderly in Detroit, Michigan. Am J Respir Crit Care Med (1994) 2.69
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology (1997) 2.46
Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol (1995) 2.40
Cardiac arrhythmia induction after exposure to residual oil fly ash particles in a rodent model of pulmonary hypertension. Toxicol Sci (1998) 2.19
Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. Am J Epidemiol (1997) 2.17
Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol (1987) 1.70
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring. Am J Cardiol (1987) 1.62
Heart rate variability. Frequency domain analysis. Cardiol Clin (1992) 1.60
Low-level air pollution and hospital admissions for cardiac and cerebrovascular diseases in Helsinki. Am J Public Health (1996) 1.49
Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol (1994) 1.47
Particulate pollution and health: a review of the Utah valley experience. J Expo Anal Environ Epidemiol (1996) 1.39
Heart rate variability. Clin Cardiol (1990) 1.27
Airborne exposures to PAH and PM2.5 particles for road paving workers applying conventional asphalt and crumb rubber modified asphalt. J Expo Anal Environ Epidemiol (1998) 1.15
Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol (1990) 1.10
Heart rate variability power spectrogram as a potential noninvasive signature of cardiac regulatory system response, mechanisms, and disorders. Heart Vessels (1987) 0.96
Velocity gradients across normal cardiac valves. Am J Cardiol (1991) 0.88
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Cost analysis of early discharge after hip fracture. BMJ (1993) 6.64
Deaths from low dose paracetamol poisoning. BMJ (1998) 6.63
Anti-tuberculous therapy and acute liver failure. Lancet (1995) 6.27
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Vulnerability genes or plasticity genes? Mol Psychiatry (2009) 4.96
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet (1990) 4.57
Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet (1971) 4.49
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet (1990) 4.27
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet (1974) 3.61
Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40
Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med (2006) 3.36
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology (2010) 3.36
Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med (1978) 3.28
Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med (1992) 3.24
NHLBI Family Heart Study: objectives and design. Am J Epidemiol (1996) 3.21
Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature (1974) 3.17
Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol (1977) 3.13
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res (1990) 3.08
Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet (1998) 3.06
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet (1973) 2.98
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
More donor organs for transplantation. Elective ventilation proposals. J R Coll Physicians Lond (1993) 2.91
Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med (1973) 2.88
Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J (1971) 2.86
The arthropathy of idiopathic haemochromatosis. Q J Med (1968) 2.85
Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) (1982) 2.85
Liver transplantation after paracetamol overdose. BMJ (1991) 2.81
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol (1997) 2.78
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Liver in Felty's syndrome. Br Med J (1970) 2.75
Estimates of dose-response for respiratory cancer among chrysotile asbestos textile workers. Ann Occup Hyg (1982) 2.73
Hepatic damage and death from overdose of paracetamol. Lancet (1973) 2.70
Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child (1976) 2.67
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med (1991) 2.65
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology (1988) 2.60
Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60
Liver transplantation. Curr Probl Surg (1979) 2.57
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53
Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut (1998) 2.51
Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychol (1995) 2.43
Developing and deploying a patient safety program in a large health care delivery system: you can't fix what you don't know about. Jt Comm J Qual Improv (2001) 2.42
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med (1995) 2.41
1 -Antitrypsin deficiency and neonatal hepatitis. Br Med J (1972) 2.40
General practice orthopaedic outpatient referrals in North Staffordshire. Br Med J (Clin Res Ed) (1983) 2.38
Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet (1974) 2.37
Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations. Adv Exp Med Biol (1997) 2.35
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol (1992) 2.31
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet (1970) 2.25
Cytomegalovirus hepatitis in the adult. Lancet (1967) 2.20
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18
Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet (1973) 2.17
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br Med J (Clin Res Ed) (1986) 2.16
Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16
Portal hypertension in idiopathic tropical splenomegaly. Lancet (1966) 2.16
Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14
Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem (1989) 2.14
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology (1995) 2.11
Target genes and regulatory domains of the GAMYB transcriptional activator in cereal aleurone. Plant J (1999) 2.11
H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet (1977) 2.10
Parametric manipulation of conflict and response competition using rapid mixed-trial event-related fMRI. Neuroimage (2003) 2.10
Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure. Br Med J (1973) 2.09
Arthropathy of haemochromatosis. Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis (1970) 2.09
Detection, treatment, and follow up of women with Chlamydia trachomatis infection seeking abortion in inner city general practices. BMJ (1989) 2.08
Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08
Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet (1971) 2.08
Cell-mediated immune responses in chronic liver diseases. Br Med J (1972) 2.05
Inheritance and expression of chimeric genes in the progeny of transgenic maize plants. Biotechnology (N Y) (1990) 2.05
Chondrocalcinosis and arthropathy: studies in haemochromatosis and in idiopathic chondrocalcinosis. Q J Med (1970) 2.03
Development and importance of health needs assessment. BMJ (1998) 2.03
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00